CAS 2770960-52-4
:BIIB129
Description:
BIIB129, also known by its CAS number 2770960-52-4, is a chemical compound that has garnered attention in the field of pharmaceutical research, particularly for its potential therapeutic applications. As a small molecule, it is designed to interact with specific biological targets, which may include proteins or enzymes involved in disease pathways. The compound's structure typically features functional groups that enhance its solubility and bioavailability, making it suitable for oral or injectable formulations. BIIB129 is under investigation for its efficacy and safety in treating certain medical conditions, and its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are crucial for determining its clinical utility. Additionally, like many investigational drugs, it undergoes rigorous testing in preclinical and clinical trials to assess its therapeutic potential and side effects. Overall, BIIB129 represents a promising candidate in the ongoing search for effective treatments in its targeted therapeutic area.
Formula:C19H22N6O2
Synonyms:- BIIB129
- 2-Propenamide, N-methyl-N-[cis-3-methyl-3-[[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]oxy]cyclobutyl]-
- N-Methyl-N-(cis-3-methyl-3-((6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
BIIB129
CAS:<p>BIIB129 is a selective and brain-penetrant BTK covalent inhibitor used to study B-cell proliferation-related diseases.</p>Formula:C19H22N6O2Purity:98.56%Color and Shape:SolidMolecular weight:366.42
